— Agilent Technologies (NYSE: A) reported its fourth-quarter 2019 adjusted earnings of $0.89 per share versus $0.85 per share expected.
— Revenue grew by 6% to $1.37 billion versus $1.33 billion expected.
— Life Sciences and Applied Markets Group sales rose 4% on continued strength in Environmental & Forensics markets.
— Agilent CrossLab Group grew by 8% on broad growth across major markets and regions, while Diagnostics and Genomics Group saw 5% growth aided by Pathology and Companion Dx and ongoing demand in Pharma for oligo-manufacturing.
— Looking ahead into the first quarter of 2020, the company expects revenue in the range of $1.34-1.355 billion and adjusted earnings of $0.80-0.81 per share. Analysts expect EPS of $0.84 on revenue of $1.38 billion.
— For the full year 2020, the company predicts revenue in the range of $5.50-5.55 billion and adjusted earnings of $3.38-3.43 per share. The consensus estimates EPS of $3.44 on revenue of $5.55 billion.
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
